Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 71 - 80 of 375

Press

OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

2018.12.04 Read more

Press

Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment

2018.11.23 Read more

Press

Recipharm CEO sells shares - remains committed and significant holder

2018.11.16 Read more

Press

Recipharm AB publishes its interim report January - September 2018

2018.11.08 Read more

Press

Invitation to presentation of Recipharm’s interim report for the third quarter 2018 on November 8

2018.11.05 Read more

Press

Manufacturing licence restriction at Recipharm Ltd, Ashton-u-Lyne, UK facility

2018.10.25 Read more

Press

Recipharm continues manufacturing operations in Höganäs, Sweden

2018.10.19 Read more

Press

Recipharm releases first serialised products to Europe

2018.10.09 Read more

Press

Recipharm welcomes Tobias Hägglöv as Chief Financial Officer

2018.10.03 Read more

Press

Recipharm completes acquisition of Sanofi inhalation contract manufacturing business

2018.10.01 Read more